Oramed Pharmaceuticals
ORMP
#9179
Rank
ยฃ0.13 B
Marketcap
ยฃ3.27
Share price
3.10%
Change (1 day)
81.03%
Change (1 year)

Oramed Pharmaceuticals (ORMP) - Cash on Hand

Cash on Hand as of June 2026 : ยฃ38.23 Million

According to Oramed Pharmaceuticals's latest financial reports the company has ยฃ38.23 Million in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Oramed Pharmaceuticals - Cash on Hand chart (from 2006 to 2026)

Cash on Hand by year

Year Cash on Hand Change
2025-12-31ยฃ93.48 M-17.35%
2024-12-31ยฃ0.11 B-11.08%
2023-12-31ยฃ0.12 B-1.18%
2022-12-31ยฃ0.12 B
2021-08-31ยฃ68.44 M129.27%
2020-08-31ยฃ29.85 M12.44%
2019-08-31ยฃ26.55 M12.95%
2018-08-31ยฃ23.5 M51.19%
2017-08-31ยฃ15.54 M-34.16%
2016-08-31ยฃ23.61 M110.58%
2015-08-31ยฃ11.21 M-12.6%
2014-08-31ยฃ12.83 M134.45%
2013-08-31ยฃ5.47 M69.76%
2012-08-31ยฃ3.22 M176.06%
2011-08-31ยฃ1.16 M49.43%
2010-08-31ยฃ0.78 M-53.6%
2009-08-31ยฃ1.68 M-39.6%
2008-08-31ยฃ2.78 M193.18%
2007-08-31ยฃ0.95 M928.97%
2006-08-31ยฃ0.09 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
Novo Nordisk
NVO
ยฃ5.18 B 13,472.30%๐Ÿ‡ฉ๐Ÿ‡ฐ Denmark
Sanofi
SNY
ยฃ5.47 B 14,219.63%๐Ÿ‡ซ๐Ÿ‡ท France
Ultragenyx Pharmaceutical
RARE
ยฃ0.22 B 476.94%๐Ÿ‡บ๐Ÿ‡ธ USA
Lexicon Pharmaceuticals
LXRX
ยฃ0.14 B 276.61%๐Ÿ‡บ๐Ÿ‡ธ USA
Compugen
CGEN
ยฃ0.10 B 166.63%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel